These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hyperpulsatile pressure, systemic inflammation and cardiac stress are associated with cardiac wall remodeling in an African male cohort: the SABPA study. van Vuren EJ, Malan L, von Känel R, Cockeran M, Malan NT. Hypertens Res; 2016 Sep; 39(9):648-53. PubMed ID: 27169396 [Abstract] [Full Text] [Related]
3. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. Neeland IJ, Drazner MH, Berry JD, Ayers CR, deFilippi C, Seliger SL, Nambi V, McGuire DK, Omland T, de Lemos JA. J Am Coll Cardiol; 2013 Jan 15; 61(2):187-95. PubMed ID: 23219305 [Abstract] [Full Text] [Related]
6. Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study). Madan N, Lee AK, Matsushita K, Hoogeveen RC, Ballantyne CM, Selvin E, McEvoy JW. Am J Cardiol; 2019 Jul 15; 124(2):245-252. PubMed ID: 31088661 [Abstract] [Full Text] [Related]
7. Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study). Seliger SL, de Lemos J, Neeland IJ, Christenson R, Gottdiener J, Drazner MH, Berry J, Sorkin J, deFilippi C. JACC Heart Fail; 2015 Jun 15; 3(6):445-455. PubMed ID: 25982111 [Abstract] [Full Text] [Related]
13. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors. Avouac J, Meune C, Chenevier-Gobeaux C, Dieudé P, Borderie D, Lefevre G, Kahan A, Allanore Y. J Rheumatol; 2014 Feb 15; 41(2):248-55. PubMed ID: 24334650 [Abstract] [Full Text] [Related]
14. IGF-1 and NT-proBNP in a black and white population: The SABPA study. Koegelenberg AS, Smith W, Schutte R, Schutte AE. Eur J Clin Invest; 2016 Sep 15; 46(9):795-803. PubMed ID: 27455178 [Abstract] [Full Text] [Related]
18. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study. Bosello S, De Luca G, Berardi G, Canestrari G, de Waure C, Gabrielli FA, Di Mario C, Forni F, Gremese E, Ferraccioli G. Eur J Intern Med; 2019 Feb 15; 60():46-53. PubMed ID: 30366614 [Abstract] [Full Text] [Related]
19. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide. Avouac J, Meune C, Chenevier-Gobeaux C, Borderie D, Lefevre G, Kahan A, Allanore Y. Arthritis Care Res (Hoboken); 2015 Jul 15; 67(7):1022-30. PubMed ID: 25604469 [Abstract] [Full Text] [Related]